---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-26-000167"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2026-09-10T20:16:12+00:00"
generated_at: "2026-09-10T20:17:11.444891+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Dexcom appoints Glenn Boehnlein, former Stryker CFO, to board

## Summary
- Board expanded to 13 directors; Boehnlein appointed effective Sept 10, 2026.
- Boehnlein is former VP & CFO of Stryker; brings MedTech financial leadership.
- Appointed to Operations & Innovation and Audit Committees.
- Received initial RSU grant worth $500,000 vesting over 3 years; annual grant $347,500.
- CEO Jake Leach cites Boehnlein's track record in growth and capital allocation.

## SEC filing metadata
- accession: 0001093557-26-000167
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2026-09-10T20:16:12+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000167/0001093557-26-000167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000167/dxcm-20260910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-26-000167
- JSON: https://secwatch.observer/filing/0001093557-26-000167.json
- Plain text: https://secwatch.observer/filing/0001093557-26-000167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.